4//SEC Filing
Seres Therapeutics, Inc. 4
Accession 0000899243-17-002121
$MCRBCIK 0001609809operating
Filed
Jan 26, 7:00 PM ET
Accepted
Jan 27, 5:51 PM ET
Size
12.0 KB
Accession
0000899243-17-002121
Insider Transaction Report
Form 4
Trucksis Michele
Chief Medical Officer and EVP
Transactions
- Award
Stock Option (right to buy)
2017-01-26+100,000→ 100,000 totalExercise: $9.89Exp: 2027-01-25→ Common Stock (100,000 underlying) - Award
Restricted Stock Units
2017-01-26+37,500→ 37,500 total→ Common Stock (37,500 underlying)
Footnotes (3)
- [F1]The option will vest as to 25% of the shares on January 26, 2018. The remainder of the shares will vest in 12 equal quarterly installments thereafter.
- [F2]Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
- [F3]These restricted stock units vest as to 20% on January 26, 2018, 30% on January 26, 2019 and 50% on January 26, 2020.
Issuer
Seres Therapeutics, Inc.
CIK 0001609809
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001609809
Filing Metadata
- Form type
- 4
- Filed
- Jan 26, 7:00 PM ET
- Accepted
- Jan 27, 5:51 PM ET
- Size
- 12.0 KB